TNDM Tandem Diabetes: Utang-utang marang kapitalisasi buku

Logo korporat perusahaan Tandem Diabetes Care Inc (TNDM)

The price action of Tandem Diabetes Care (TNDM), whose metrics are recorded at 5.51, demonstrates a struggle for leadership in the diabetes management systems segment amid the threat of autonomous organ development. Revenue growth is currently fueled by global demand for compact Mobi pumps, despite the impact of GLP-1 drugs. However, international trade disputes and logistical disruptions in Asia could limit the expansion of the company's electronics.

Tandem Corp - Utang-utang marang aset resik TNDM (periode 04.07.2022 - 30.10.2026)
Produk asli Tandem Diabetes Care Inc

The long-term reliability of Tandem Diabetes Care (TNDM) is determined by the balance between borrowed funds and equity, where the percentage of debt participation in balance sheet capital measures the degree of financial leverage and the risk of liquidity loss. The trend of this ratio confirms the issuer's high resilience, as stable demand for medical devices isolates the company's capital structure from macroeconomic shocks and market volatility.

Pesaing langsung

Utang-utang marang kapitalisasi buku BSX (Boston Scientific)|edwards.com (EW) - Utang-utang marang nilai buku|ResMed - Utang-utang marang kapitalisasi buku|Insulet Corp (PODD) - Utang marang nilai buku|ZBH: Utang-utang marang kapitalisasi buku|COO - Utang-utang marang aset resik|ALGN (Align Technology, Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku globusmedical.com|Rasio utang marang kapitalisasi buku TransMedics Organ Care System (TMDX)|Rasio utang marang kapitalisasi buku ATEC (Alphatec Holdings)|Utang-utang marang kapitalisasi buku AORT (Artivion Inc)|Utang-utang marang aset resik Enovis Inc. (ENOV)|IART: Utang marang nilai buku|Rasio utang-utang marang kapitalisasi buku ESTA|BBNX: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku IRADIMED Corp (IRMD)|EMBC (Embecta Inc.) - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku AXGN (Axogen Surgical)|Utang marang nilai buku SIBN (SI-BONE, Inc.)|OFIX (orthofix.com) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku Bioventus BVS|KIDS - Utang marang nilai buku|Treace Medical - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Strata Medical|CARL: Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku RXST|CLPT (ClearPoint Neuro Inc.) - Utang-utang marang kapitalisasi buku|Stereotaxis Inc (STXS) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku STIM|Utang marang nilai buku Sight Sciences Inc SGHT|Utang-utang marang kapitalisasi buku OBIO (Orchestra BioMed, Inc.)|Utang-utang marang kapitalisasi buku Anika Therapeutics Inc. ANIK|NSPR - Rasio utang marang kapitalisasi buku|ZJYL: Rasio utang marang kapitalisasi buku|VANI (vivani.com) - Utang marang nilai buku|Xtant Medical - Rasio utang marang aset resik|NMTC (NeuroOne Medical Technologies) - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Modular Med MODD|Rasio utang marang kapitalisasi buku Myomo (MYO)|Envoy Medical Inc. (COCH) - Utang marang aset resik|Vivos Therapeutics, Inc - Utang marang nilai buku|Utang-utang marang kapitalisasi buku enVVeno Corp NVNO|SINTX Technologies - Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik tenonmed.com TNON|Lifeward (LFWD) - Rasio utang marang kapitalisasi buku|Rasio utang-utang marang kapitalisasi buku AMIX (Autonomix Medical)|Rasio utang marang kapitalisasi buku INVO Bioscience, Inc.|Utang marang nilai buku Bone Biologics Inc (BBLG)|Utang-utang marang kapitalisasi buku AXNX|BIOL - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Dynatronics DYNT|FNA: Rasio utang marang nilai buku|INVO: Utang marang nilai buku